Michel, Alexander http://orcid.org/0000-0002-8107-5818
Lecomte, Coralie
Ohlmeier, Christoph
Raad, Hanaya
Basedow, Frederike
Haeckl, Dennis
Beier, Dominik
Evers, Thomas
Funding for this research was provided by:
Bayer
Article History
Accepted: 19 March 2024
First Online: 4 April 2024
Declarations
:
: Alexander Michel, Christoph Ohlmeier, and Thomas Evers are employees of Bayer. Coralie Lecomte is an employee of Aetion, Inc. and holds stock options of Aetion, Inc. Hanaya Raad was an employee of Aetion Inc. at the time of the study and holds stock options of Aetion Inc. Dennis Häckl is an employee of WIG2 GmbH, which has received funding from Bayer AG. Frederike Basedow and Dominik Beier are employed by InGef, which acted as a subcontractor and received funding from WIG2 for the execution of the study.
: This study was funded by Bayer AG (grant number, not applicable).
: This was a retrospective study using de-identified administrative data that received waiver of authorization for use and disclosure of protected health information from US WIRB-Copernicus Group institutional review board on 1 December 2021. No additional approval was required for use of the InGef database due to the data being anonymized.
: Not applicable.
: Study concept: A Michel, C Ohlmeier, T Evers. Study design: A Michel, C Lecomte, C Ohlmeier. Analysis of data: H Raad, F Basedow, D Beier. Interpretation of data: A Michel, C Lecomte, C Ohlmeier, D Häckl, D Beier. Writing the first manuscript draft: A Michel. Review of subsequent manuscript drafts: all authors. Approval of the final version for publication: all authors.
: Aggregated data are available from the corresponding author upon reasonable request.